We are live on
!
Find out more
Vanguard Global Advisers Portfolio holdings
AUM
$215B
This Fund
S&P 500
This Quarter
Est. Return
+22.32%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$215B
AUM Growth
+$28.1B
(+15%)
Cap. Flow
+$1.96B
Cap. Flow
% of AUM
0.91%
Top 10 Holdings %
Top 10 Hldgs %
41.33%
Holding
3,754
New
71
Increased
744
Reduced
1,650
Closed
116
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$1.11B |
| 2 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$688M |
| 3 |
Marvell Technology
MRVL
|
+$294M |
| 4 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$214M |
| 5 |
Royal Bank of Canada
RY
|
+$166M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$189M |
| 2 |
Honeywell
HON
|
+$157M |
| 3 |
Apple
AAPL
|
+$124M |
| 4 |
Microsoft
MSFT
|
+$89M |
| 5 |
Amazon
AMZN
|
+$62.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.83% |
| 2 | Financials | 11.43% |
| 3 | Communication Services | 6.64% |
| 4 | Consumer Discretionary | 6.57% |
| 5 | Industrials | 6.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PVLA
1776
Palvella Therapeutics
PVLA
$2.21B
| $949K | ﹤0.01% |
6,209
| – | – |
|
1777
Westlake Corp
WLK
$9.99B
| $948K | ﹤0.01% |
12,989
-922
| -7% | -$90K |
|
1778
Lifestance Health
LFST
$4.79B
| $947K | ﹤0.01% |
88,418
+4,773
| +6% | +$36.9K |
|
1779
Interface
TILE
$2.2B
| $945K | ﹤0.01% |
26,372
-1,228
| -4% | -$35.9K |
|
1780
Bioventus
BVS
$1.17B
| $945K | ﹤0.01% |
100,117
+2,565
| +3% | +$24.5K |
|
|
MANE
1781
Veradermics Inc
MANE
$4.52B
| $945K | ﹤0.01% |
7,687
+939
| +14% | +$88K |
|
1782
Artisan Partners
APAM
$2.94B
| $941K | ﹤0.01% |
27,246
-1,467
| -5% | -$54K |
|
1783
Tarsus Pharmaceuticals
TARS
$3.1B
| $941K | ﹤0.01% |
14,946
-1,481
| -9% | -$94.6K |
|
1784
AnaptysBio
ANAB
$1.77B
| $940K | ﹤0.01% |
13,919
+2,165
| +18% | +$131K |
|
1785
Intellia Therapeutics
NTLA
$1.69B
| $939K | ﹤0.01% |
55,491
+8,795
| +19% | +$123K |
|
1786
Nu Skin
NUS
$228M
| $937K | ﹤0.01% |
177,387
-51,839
| -23% | -$331K |
|
1787
Monte Rosa Therapeutics
GLUE
$1.31B
| $935K | ﹤0.01% |
38,635
+2,637
| +7% | +$49.8K |
|
1788
Teladoc Health
TDOC
$1.19B
| $932K | ﹤0.01% |
109,961
-32,761
| -23% | -$218K |
|
|
LINE
1789
Lineage Inc
LINE
$9.29B
| $932K | ﹤0.01% |
21,554
-1,259
| -6% | -$49.5K |
|
1790
LiveRamp
RAMP
$2.29B
| $932K | ﹤0.01% |
24,756
-79,867
| -76% | -$2.63M |
|
1791
Midland States Bancorp
MSBI
$691M
| $931K | ﹤0.01% |
29,895
+2,194
| +8% | +$59.1K |
|
1792
BancFirst
BANF
$3.86B
| $930K | ﹤0.01% |
8,366
+17
| +0.2% | +$1.9K |
|
1793
Green Brick Partners
GRBK
$3.05B
| $930K | ﹤0.01% |
11,614
-570
| -5% | -$39.4K |
|
1794
Origin Bancorp
OBK
$1.66B
| $926K | ﹤0.01% |
18,109
| – | – |
|
1795
BioCryst Pharmaceuticals
BCRX
$2.54B
| $925K | ﹤0.01% |
92,513
-5,738
| -6% | -$51.9K |
|
1796
Neogen
NEOG
$2.59B
| $921K | ﹤0.01% |
102,429
+17,848
| +21% | +$164K |
|
1797
Lincoln Educational Services
LINC
$911M
| $920K | ﹤0.01% |
18,429
+7,228
| +65% | +$327K |
|
1798
ProPetro Holding
PUMP
$1.57B
| $920K | ﹤0.01% |
64,125
+22,292
| +53% | +$346K |
|
1799
Fortrea Holdings
FTRE
$1.72B
| $917K | ﹤0.01% |
52,708
-83,532
| -61% | -$1.13M |
|
1800
DNOW Inc
DNOW
$2.92B
| $916K | ﹤0.01% |
70,634
-2,686
| -4% | -$34.9K |
|
Similar funds
Vanguard Global Advisers's Q2 2026 Portfolio in Review
As of Q2 2026, Vanguard Global Advisers held 3,754 positions worth $215B, up 15% from $187B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Trading was light in Q2 2026: portfolio turnover was 5%. Vanguard Global Advisers opened 71 new positions and exited 116, leaving the 3,754-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 23% a quarter earlier, followed by Financials and Communication Services.
- Vanguard Global Advisers's largest Q2 2026 buy was Honeywell Aerospace: 682,434 shares worth $151M.
- Vanguard Global Advisers added most to Vanguard S&P 500 ETF in Q2 2026, an estimated $1.11B increase.
- Vanguard Global Advisers's biggest Q2 2026 reduction was NVIDIA, cutting an estimated $189M.
- Vanguard Global Advisers fully exited Coterra Energy in Q2 2026, selling an estimated $58.2M.
- Vanguard Global Advisers's ten largest holdings make up 41% of its $215B portfolio in Q2 2026.
- Vanguard Global Advisers opened 71 new positions and closed 116 in Q2 2026.
- Vanguard Global Advisers's portfolio value rose 15% quarter-over-quarter to $215B.
Based on Vanguard Global Advisers's 13F filing for Q2 2026, filed 13 Aug 2026.